SAN JOSE, Calif., July 13 /PRNewswire/ -- Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for biologics applications today announced a development agreement with Biogen Idec, Inc. aimed at evaluating emerging technologies for single-use bioprocessing. These technologies include novel disposable sensors, software platforms, and control algorithms.
Dr. Mark Selker, Chief Technology Officer and founder of Finesse, stated,"We are delighted to have the efforts of world-class scientists at Biogen Idec help refine our technologies and focus our development. This will go far in helping to optimize our products using actual cell culture platforms."
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at www.finesse.com.
Finesse Solutions, LLC